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Abstract In this paper, we have proposed a simple method to
covalently conjugate biotin to magnetic nanoparticles, which
can be targeted to the tumour sites by using pretargeting
approach with avidin or streptavidin. Magnetic nanoparticles
of manganese ferrite were synthesized by alkaline copreci-
pitation of ferric chloride hexahydrate, ferrous sulphate
heptahydrate and manganese sulphate monohydrate using
ammonium hydroxide. The synthesized magnetic nanopar-
ticles were then successfully surface modified by using 3-
aminopropyl trimethoxysilane, and the amount of amino-
propylsilane bound to the surface of magnetic nanoparticles
was quantified by measuring the absorbance of a purple-
coloured complex (Ruhemann’s purple) formed between
amine group and ninhydrin at 576 nm. The aminated
magnetic nanoparticles were then conjugated to biotin by
reacting them with N-hydroxysuccinimide–biotin in dime-
thylsulphoxide. The successful conjugation of biotin to
magnetic nanoparticles was confirmed by Fourier transform
infrared spectroscopy. The size, phase and magnetic nature of
the synthesized nanoparticles were analysed by using various
techniques like transmission electron microscopy, X-ray
diffraction, energy-dispersive X-ray spectroscopy and vibrat-
ing sample magnetometry.
Keywords Pretargeted magnetic nanoparticles .
3-Aminopropyltrimethoxysilane (APS) . Ruhemann’s
purple . Biotinylation . Superparamagnetic behaviour . EDX
1 Introduction
Magnetic particles are interesting candidates for various
applications like cell separation (Sieben et al. 2001; Begg et
al. 2002), hyperthermia (Hilger et al. 2005), embolotherapy
(Lee et al. 2005), targeted drug delivery, diagnosis and
therapy (Zhang et al. 2008; Bulte et al. 1992; Go et al.
1993; Kohler et al. 2005) of tumour because of their fine
magnetic properties. As magnetic nanoparticles are finding
increasing uses day by day, their use for a particular
application is mainly governed by their size. Particularly for
in vivo applications, their size range plays a very important
role, e.g. nanometer-sized particles can be used in diagnosis
and therapy of tumours, while particles in the micro range are
used in cell separation and embolotherapy. Nowadays, many
methods are available to synthesize magnetic nanoparticles,
but the need is to develop methods which are easy to apply
and can produce magnetic nanoparticles with uniform or
narrow size distribution range. Another factor which is
important is their stability in vivo, which can be achieved by
modifying their surface with some organic molecules that
shield them from different physiological conditions within the
body post-administration. These molecules provide stealth
character to the magnetic nanoparticles by adopting any one of
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the three most probable structures as given by Wu et al.
(2008), i.e. core shell, mosaic structure and shell core shell
structure. In recent years, many approaches have been used
for this purpose and also to make them stable. The most
common of them is to modify their surface with a
biodegradable and biocompatible polymer. Of the various
polymers that are commonly employed to make them stable
are polyethylene glycol (Zhang et al. 2002), polyvinyl alcohol
(Thorek et al. 2006; Cerda et al. 2007), poly-L-lysine (Babic
et al. 2008), dextran (Mornet et al. 2005) and carboxymethyl
dextran (Horak et al. 2007). All these materials have long
chains and functional groups, out of which the chains are
adsorbed on the surface of the particles and the functional
groups are projected outwards, which helps in providing
them stability in physiological medium and also the reacting
sites for further modification. Some other molecules which
are currently being explored for this purpose are dopamine
(Xu et al. 2004), aminopropylsilanes (Iida et al. 2005), amino
acids like glutamic acid (Sousa et al. 2001), lysine (Durmus
et al. 2009), cystine (White et al. 2009), etc. In this work, we
have chosen 3-Aminopropyltrimethoxysilane (APS) (Ma et
al. 2003; Yamaura et al. 2004) as surface-modifying agent
because of its strong binding ability to various surfaces, as it
can form strong covalent bond with them and particularly
with the ferrites. The bonding of the ferrites with amino-
propyltrialkoxysilanes resulted due to the formation of Fe–
O–Si covalent linkage which is quite strong and hence helps
further in conjugation because of having free amino group
which can be easily modified. The next step in utilizing these
nanoparticles for in vivo applications particularly in diagno-
sis and therapy of tumours is to make them target specific,
which can be achieved by modifying their surface with some
targeting agents. Various agents that can be used or are
currently being explored for targeting tumours are folic acid
(Mohapatra et al. 2007; Sudimack and Lee 2000), Arginine–
Glycine–Aspartic acid (RGD) peptides (Lee et al. 2009; Su
et al. 2002; Montet et al. 2006; Xie et al. 2008; Lee et al.
2008), chlorotoxin (Sun et al. 2008) and various antibody
conjugates. Folic acid is quite commonly used to target
various types of cancers as its receptors which are
glycosylphosphatidylinositol derivatives are overexpressed
on many types of cancers including breast, lung, cervical,
brain metastasis and renal cell carcinomas (Gabizon et al.
1999; Stella et al. 2000). The RGD peptides which contain
arginine–glycine–aspartic acid sequence are used to target
ανβ3 integrin receptors which are markers of tumour
angiogenesis and are significant in early cancer detection.
Chlorotoxin, a 36-amino acid peptide, binds specifically to
glioma (Veiseh et al. 2005), medulloblastoma, prostate cancer,
sarcoma and intestinal cancer (Veiseh et al. 2007) that
overexpresses membrane-bound matrix metalloproteinase-2.
We chose biotin as an agent to target the magnetic
nanoparticles to the tumours because of its strong binding
affinity with avidin and streptavidin as the interaction
between them is among the strongest known noncovalent
interactions which are stable at wide range of temperatures
(up to 120°C) and pH (2–13), thus providing a good
opportunity for in vivo targeting. Also, the avidin can bind
four biotin units per molecule, thus biotin–avidin system
provides a very good platform for targeting various
biotinylated agents to the tumours. The high isoelectric point
(10.5) and good degree of glycosylation (Tannous et al.
2006; Sakahara and Saga 1999) of avidin are other prime
actors which help in the tumour uptake of the avidin. Hence,
APS = 3-Aminopropyltrimethoxysilane, MNP= Magnetic nanoparticle 
MNP-APS = Aminopropyltrimethoxysilane conjugated magnetic nanoparticle
MNP-APS-Biotin = Biotin conjugated magnetic nanoparticles
Fig. 1 A pictorial representation
of strategy used for conjugation
of biotin to manganese ferrite
nanoparticles
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the biotin and biotinylated agents can be easily targeted to
the tumours by using the affinity of biotin to the avidin.
Another plus point of using the biotin–avidin system is that
the avidin acts as a chase to remove the extra biotinylated
(Tilborg et al. 2008) agent from the circulation and helps in
differentiating the targeted site from the background. So, by
targeting the magnetic nanoparticles to the tumour sites by
exploiting the well-known affinity of biotin and its deriva-
tives to the avidin or streptavidin, great advancements can be
achieved in tumour diagnosis using contrast-enhanced
magnetic resonance imaging (MRI). The synthetic strategy
used for conjugating biotin to magnetic nanoparticles is
shown in Fig. 1.
2 Experimental
2.1 Materials
Ferric chloride hexahydrate, ferrous sulphate heptahydrate,
manganese sulphate monohydrate, ammonium hydroxide,
dimethylsulphoxide (DMSO), N,N-dimethylformamide
(DMF), methanol, toluene and diethyl ether were purchased
from Merck. Biotin, APS, ninhydrin, N-hydroxysuccinimide
(NHS), N,N-dicyclohexylcarbodiimide (DCC) were from
Sigma Chemical Co. All chemicals were used as received
without further purification until mentioned by the supplier.
For all purposes, wherever water is required, ultrapure milli-Q
water was used.
2.2 Synthesis of manganese ferrite nanoparticles
Magnetic nanoparticles of manganese ferrite were synthesized
by alkaline coprecipitation (Bautista et al. 2005; Lee et al.
2004) of ferric chloride hexahydrate, ferrous sulphate
heptahydrate and manganese sulphate monohydrate using
ammonium hydroxide. Briefly, 0.086 mol of ferric chloride
hexahydrate, 0.0344 mol of ferrous sulphate heptahydrate and
0.0086 mol of manganese sulphate monohydrate were
dissolved completely in 50 ml of water, and the resultant
metal ion solution was added dropwise to a 50-ml ammonium
hydroxide solution under constant stirring followed by
sonication. The synthesized suspension of magnetic nano-
particles was then collected on a Whatman filter paper,
washed with water till the filtrate is free of alkalinity and
dried in an oven (60–70°C) to obtain brown powder of
magnetic nanoparticles.
2.3 Surface modification of magnetic nanoparticles
with 3-Aminopropyltrimethoxysilane
The conjugation of APS (Xu et al. 1997) to the surface of
the magnetic nanoparticles was done by dispersing 50 mg
of magnetic nanoparticles in 25 ml of toluene under
sonication for 20 min and then adding 250 mg of 3-
aminopropyl trimethoxysilane to it and kept stirring the
reaction mixture for 24 h at room temperature. The
aminated magnetic nanoparticles were then collected by
using a magnet and were then washed two times with
toluene and three times with methanol and were then
Fig. 2 X-ray diffraction spectrum of synthesized manganese ferrite
nanoparticles Fig. 3 EDX spectrum of synthesized manganese ferrite nanoparticles
Table 1 Measured lattice spacing (d) and standard lattice spacing of
manganese ferrite nanoparticles (Lu et al. 2009) with their hkl indexes
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dried in an oven at 50°C and were stored in a vacuum
desiccator.
2.4 Synthesis of N-hydroxysuccinimide–biotin
N-Hydroxysuccinimide–biotin (NHS–biotin) was synthe-
sized according to earlier reported procedure (Susumu et
al. 2007) by reacting biotin with N-hydroxysuccinimide
(NHS) and DCC in a molar ratio of 1:1.1:1.2 in dry DMF
under nitrogen atmosphere at 35°C for 24 h. The crude
NHS–biotin was stored at 4°C to crystallize out dicyclo-
hexylurea crystals which were then removed by filtering.
The NHS–biotin was then precipitated by adding ten times
volume of cold diethyl ether and was again washed with
ether.
2.5 Conjugation of NHS–biotin to aminated magnetic
nanoparticles
For conjugating biotin to aminopropyl trimethoxysilane-
modified magnetic nanoparticles, 108 mg of NHS–biotin
was dissolved in 5 ml of dry DMSO, and then, 12 mg
of 3-aminopropyl trimethoxysilane-modified magnetic
nanoparticles were added to it and kept stirring the
reaction mixture for 48 h. The resulting biotinylated
magnetic nanoparticle suspension was then centrifuged
Fig. 4 a FTIR spectra of as
synthesized manganese ferrite
nanoparticles (black), APS (red)
and APS conjugated manganese
ferrite nanoparticles (blue). b
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at 10,000 rpm at 4–5°C for 10 min so as to collect the
biotinylated magnetic nanoparticles which were then
washed eight to nine times with ultrapure milli-Q water
so as to completely remove DMSO. The resulting
biotinylated magnetic nanoparticles were then dried in
an oven at 50°C and stored in a vacuum desiccator.
2.6 Characterization
Phase identification of the synthesized metal ferrite nano-
particles was done by powder X-ray diffraction method using
CuKα1 (1.54060 A
0) radiation on X-Pert Pro-Pan analytical
model, and the average particle size was calculated using
Scherer equation (i.e. t=0.9λ/B cos θ). Fourier transform
infrared spectroscopy (FTIR) spectra of all samples in the
range of 400–4,000 cm−1 were recorded by using KBr pellet
method using Perkin Elmer, Spectrum-BXII FTIR Instru-
ment. UV–visible measurements were carried out by using
double beam UV–Visible spectrophotometer 5704SS model,
Electronics Corporation of India Limited. Morphology and
particle sizes were examined by using a transmission electron
microscope (TEM). Magnetic measurement study was carried
out by using Vibrating Sample Magnetometer (VSM) ADE
model EG5. Nuclear magnetic resonance (NMR) spectra












3,361, 3,294 νas (N–H) and νs (N–H)3-Aminopropyltrimethoxysilane (APS)
2,941, 2,842 νas (C–H) and νs (C–H)
1,596 δ (NH2)
1,469 δ (C–H)
1,192, 1,084 Si–O–C stretching
3,348 ν (N–H)
APS-modified manganese ferrite 2,928 ν (C–H)
1,560 δ (NH2)
1,490 δ (C–H)
1,114, 1,027 Si–O–Si and Si–O–Fe linkages
586,446 M–O stretching
3,361 ν (O–H) of –COOH
3,308 ν (N–H)
Biotin 2,969, 2,933 νas (C–H) and νs (C–H)
1,706, 1,689 ν (C=O) of –COOH
1,639 ν (C=O) of –CONH
1,480, 1,319 δ (C–H) and δ (NH)
1,015 ν (C–O) of –COOH
3,233 ν (N–H)
2,941 ν (C–H)
NHS–biotin 1,819, 1,789 ν (C=O)
1,748, 1,731, 1,705 ν (C=O)
1,470, 1,370 δ (C–H) and δ (NH)
1,217, 1,072 ν (N–O) and ν (C–O) of ester
3,252 ν (N–H)
2,924 ν (C–H)
Biotin-conjugated manganese ferrite 1,684 ν (C=O) amide I
1,558 δ (N–H) amide II
1,467 δ (C–H)
1,134, 1,023 Si–O–Si and Si–O–Fe linkages
589,435 M–O stretching
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were taken on a Bruker 400 MHz NMR spectrometer. Mass
spectrum was recorded using Agilent 6310 ion trap LCMS.
3 Results and discussion
3.1 X-ray diffraction study
X-ray diffraction spectrum of synthesized magnetic nano-
particles (Fig. 2) shows peaks at 2θ=30° (220), 35° (311),
43° (400), 53° (422), 57° (511), 63° (440) and 74° (533)
which corresponds to the spinel phase. Lattice spacing
measurements are in close agreement with those with
the standard spacing of manganese ferrite (Lu et al.
2009) at their respective hkl indexes (Table 1), which
proves that the synthesized nanoparticles are of manga-
nese ferrite. Further, the occurrence of broadness at the
base of peaks indicates that the particle size is very small.
Average crystallite size calculated using Debye–Scherer
equation (i.e. t=0.9λ/B cosθ) is around 10.46 nm.
3.2 Energy-dispersive X-ray spectroscopy study
The energy-dispersive X-ray spectroscopy (EDX) spectrum
of synthesized manganese ferrite nanoparticles (Fig. 3)
shows peaks corresponding to energy of X-ray emitted,
which is characteristic of manganese and iron. This again
supports our X-ray diffraction (XRD) results that the
synthesized nanoparticles are of manganese ferrite. The
weight percentage of manganese calculated using EDX
analysis is found to be 4.09% which is very close to the
experimental used percentage of manganese which is
4.24%, and the weight ratio of Mn/Fe/O is found to be
4.09:58.69:37.22.
3.3 FTIR spectroscopic study
The successful conjugation of APS to the surface of
magnetic nanoparticles is proved by FTIR. The major
peaks in the spectra (Fig. 4a) of manganese ferrite were
assigned to M–O str. at 573 and 452 cm−1. The peaks in the
spectra of APS were due to N–H str. (asym and sym) at
3,361 and 3,294 cm−1, C–H str. (asym and sym) at 2,941
and 2,842 cm−1, N–H def at 1,596 cm
−1, C–H def at
1,469 cm−1, 1,192 and 1,084 cm−1 due to Si–O–C
stretching. The peaks in the spectra of APS-conjugated
manganese ferrite were 3,348 cm−1 (N–H str.), 2,928 cm−1
(C–H str.), 1,560 (N–H def), 1,490 (C–H def), 1,114 and
1,027 cm−1 due to Si–O–Si and Fe–O–Si linkages, 586 and
446 cm−1 due to M–O str. By comparison of the infrared
(IR) spectra of synthesized manganese ferrite nanoparticles,
APS and APS-modified magnetic nanoparticles, we can
clearly see a major shift in the various modes of vibrations
Fig. 5 a UV–visible absorbance spectra of aminated magnetic
nanoparticles (red), ninhydrin (black) and ninhydrin complex of
aminated nanoparticles (green). b Plot of molar concentration of
APS–ninhydrin complex versus absorbance at 576 nm
Fig. 6 a TEM image of synthesized manganese ferrite nanoparticles.
b TEM image of biotin-conjugated manganese ferrite nanoparticles
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which proves that APS is successfully conjugated cova-
lently to the surface of magnetic nanoparticles. The
successful conjugation of biotin to the aminated nano-
particles is explained clearly by comparing the IR spectra of
biotin, NHS–biotin and biotinylated magnetic nanoparticles
(Fig. 4b). The peaks in the spectra of biotin-conjugated
magnetic nanoparticles were 3,252 cm−1 (N–H str.), 3,076,
2,924 cm−1(C–H str.), 1,684 cm−1 (C=O str.), 1,640 cm−1
Fig. 7 a 1H-NMR spectrum
of NHS–biotin. b 13C-NMR
spectrum of NHS–biotin. cMass
spectrum of NHS–biotin
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(C=O str.), 1,558 cm−1 (N–H def), 1,467 cm
−1 (C–H def),
1,134 and 1,023 cm−1 (Si–O–Si and Si–O–Fe) linkages, 589
and 435 cm−1 due to M–O str. A comparison of the different
vibrational modes of manganese ferrite nanoparticles, APS,
APS-modified manganese ferrite, biotin, NHS–biotin and
biotinylated magnetic nanoparticles is given in Table 2.
3.4 UV–visible spectroscopy study
The presence of APS bound to the surface of nanoparticles
was also confirmed by UV–visible spectroscopy in addition
to FTIR and estimated quantitatively by measuring the
absorbance of the purple-coloured complex formed by its
reaction with ninhydrin. Ninhydrin, on reaction with amino
group containing compounds like amines and amino acids,
forms a purple-coloured (McCaldin 1960; Rahman and
Kashif 2003) complex (Ruhemann’s purple) which absorbs
at 576 nm. For determining quantitatively the amount of
APS bound to the surface of the nanoparticles, a plot of
molar concentration versus absorbance (at 576 nm) of
ninhydrin complex of pure APS was drawn, and then, the
amount of APS bound to the surface of nanoparticles was
determined from the graph. The UV–visible absorbance
spectrum of ninhydrin complex of aminated magnetic
nanoparticles is shown in Fig. 5a. The presence of a band
at 576 nm due to the formation of a purple-coloured
complex between APS conjugated to magnetic nanopar-
ticles and ninhydrin again proves the presence of APS on
the surface of magnetic nanoparticles. For UV–visible
measurements, all samples were prepared in methanol.
The amount of APS bound to the surface of nanoparticles,
determined by plotting the absorbances obtained at 576 nm
versus different concentrations of APS–ninhydrin complex
(Fig. 5b), was found to be 2.68×10−5 mol per milligram of
magnetic nanoparticles which is slightly lesser than the
theoretical value of 2.79×10−5 mol.
3.5 Transmission electron microscopy
The TEM image of bare manganese ferrite nanoparticles
(Fig. 6a) shows that particles are nearly spherical in shape
with slight aggregation and having size in the range of (10±4)
nm which is very close to that measured by XRD. The TEM
image of biotin-conjugated manganese ferrite nanoparticles
(Fig. 6b) also shows spherical particles with almost the same
size, but their aggregation is reduced as compared to bare
particles.
3.6 NMR spectroscopic and mass spectrometric study
The synthesis of NHS–biotin was confirmed by proton
NMR (1H-NMR; Fig. 7a), carbon NMR (13C-NMR;
Fig. 7b) and mass (Fig. 7c) spectrometry. The following
are the details: 1H-NMR (400 MHz, DMSO-d6), δ 6.42 (s,
1H, N–H), 6.36 (s, 1H, N–H), 4.29 (t, 1H), 4.13 (t, 1H),
3.09 (m, 1H), 2.79 (s, 4H), 2.65 (t, 2H), 1.63 (m, 2H), 1.43
(m, 2H), 1.39 (m, 2H). 13C-NMR 170.7, 169.4, 163.2, 61.4,
59.6, 55.8, 36.3, 31.2, 28.5, 28.2 25.8, 24.8 Mass spectrum
(electron spray ionization); ion polarity, positive; calculated
mass=341.38 (C14H19N3O5S); observed mass=365.5 due
to [M+Na]+.
3.7 Vibrating sample magnetometer study
By comparison of the magnetic susceptibility measure-
ment graphs (Fig. 8) of synthesized manganese ferrite
Fig. 8 Magnetization curve of
synthesized manganese ferrite
(black), APS conjugated
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nanoparticles (σs=44.5 emu/g), APS-modified nanopar-
ticles (σs=19.6 emu/g) and that of biotinylated manganese
ferrite nanoparticles (σs=16.9 emu/g), we can clearly see a
decrease in saturation magnetization after conjugation of
APS and biotin. This decrease in saturation magnetization
is due to the diamagnetic contribution from these surface-
conjugated (APS and biotin) organic molecules which
reduces the net magnetization. To elaborate further, the
reason behind the reduction in saturation magnetization is
that the overall size of the particle increases after
conjugation of these organic molecules, but the size of
the core remains the same as the reaction takes place
only on the surface of the particle. So, after conjugation
of these organic molecules, the overall particle size goes
on increasing due to increase in the thickness of the
organic layer around the core as we found later, but the
core size remains the same, and as we know that the
magnetism is only due to the core, so there is a
decrease in saturation magnetization after conjugation of
APS and biotin. By using the formula [σs=σs (bulk) (1−6t/d)]
for calculating the thickness (t) of dead layer on the
surface of magnetic nanoparticles and using the saturation
magnetization value of bulk manganese ferrite (80 emu/g)
as given by Zheng et al. (1998) and also by putting the
average size (d), i.e. 10.4 nm in our case, the thickness of
APS and biotin was found to be 0.53 and 0.07 nm,
respectively. The thickness of APS and biotin layer
obtained from magnetization data shows that after conju-
gation of APS, the increase in size was 0.53 nm and
decrease in magnetization was 24.9 magnetization units,
and after conjugation of biotin, size increase was 0.07 nm
only w.r.t. APS-conjugated magnetic nanoparticles. This
biotin layer formed is very thin as compared to the APS
layer; therefore, there was a small decrease (2.7 units) in
magnetization after conjugation of biotin. The total
increase in thickness after conjugation of both APS and
biotin is so small (i.e. only 0.60 nm) that it is not
detectable in normal TEM instruments as observed from
our TEM results. From Fig. 8, it is clear that all three
samples are typically super paramagnetic in nature with no
noticeable hysteresis. But to our interest, magnetic nano-
particles retained their super paramagnetic behaviour even
after surface conjugation of biotin, which is good for
exploiting it in contrast-enhanced MRI by using the ability
of biotin and biotinylated agents to bind to avidin-
pretargeted sites.
4 Conclusion
We developed a method to conjugate biotin to the surface of
magnetic nanoparticles by using a simple and easy to apply
chemical approach. The amount of APS bound to magnetic
nanoparticles was determined quantitatively by using
ninhydrin. Employing the formula reported earlier for
determining the thickness of dead layer on the surface of
magnetic nanoparticles, we successfully calculated the
thickness of APS and biotin layer bound to the surface of
magnetic nanoparticles. The successful conjugation of
biotin to magnetic nanoparticles and their super paramag-
netic behaviour, evident from FTIR and VSM, suggest that
the synthesized biotinylated magnetic nanoparticles could
be a useful agent in contrast-enhanced MRI.
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